BNET Industries

ART Advanced Research Technologies Inc.

ARA is in the Health Care Industry

Market Cap:$1.1B
Last Fiscal Year Sales:$246.3M
  • Public
  • CA
Dow Jones Description

Developer, Mfr & Marketer of Optical Imaging Products

President & CEO
Sebastien Gignac
Number of Employees 64
Contact Information

2300 Alfred Nobel Blvd

Saint Laurent, Quebec H4S 2A4

www.art.ca

(514) 832-0777

NAICS Code Analytical Laboratory Instrument Manufacturing: 334516

Recent Events

  • ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009

    9/23/09 - Product Announcement - View Story

  • ART Advanced Research Technologies Announces Second Quarter 2009 Financial Results ART reported revenues of $1.0...

    8/13/09 - Financial Announcement - View Story

News & Analysis

art advanced research technologies inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Sebastien Gignac President & CEO
Jacques Bedard CFO
Joe Kozikowski Chief Medical Officer
Warren G. Baker COO
Mario Khayat Vice President, Optical Products
Pierre Couture Vice President, Sales & Marketing
Andreas Mirow Marketing Manager, Product
Carlos Marques General Manager, Product

Board of Directors

Name (plus bio) Position
Benoit La Salle Chairman
George N Fugelsang Board of Directors
Jacques Courville Board of Directors
Pierre Dutheil Board of Directors
Raymond Cyr Board of Directors
Rierre Dutheil Board of Directors

Organization Position Status
ART Advanced Research Technologies, Inc. President & CEO Current
ART Advanced Research Technologies, Inc. Board of Directors Current
ART Advanced Research Technologies, Inc. General Counsel & Secretary Former

Organization Position Status
ART Advanced Research Technologies, Inc. CFO Current

Organization Position Status
Clinivation, Inc. President & CEO Current
ART Advanced Research Technologies, Inc. Chief Medical Officer Current
Proformant, Inc. Chairman and Managing Partner of Proformant Current
Proformant, Inc. CEO Former
Massachusetts Gen Hospital Principal Investigator Former
Massachusetts General Hospital Principal Investigator Former
Johnson & Johnson Former
Biogen, Inc. Former
Rigid Building Systems Ltd. Former
Mallinckrodt Inc. Former
Villanova University Former
Johns Hopkins University School of Medicine Former

Organization Position Status
ART Advanced Research Technologies, Inc. COO Current
Hewlett-Packard Company program manager Former

Organization Position Status
ART Advanced Research Technologies, Inc. Vice President, Optical Products Current

Organization Position Status
ART Advanced Research Technologies, Inc. Vice President, Sales & Marketing Current
Mallinckrodt Inc. Former
Tyco International Ltd. Former
McGill University Advanced Management Course for Senior Executives Former

Organization Position Status
ART Advanced Research Technologies, Inc. Marketing Manager, Product Current

Organization Position Status
ART Advanced Research Technologies, Inc. General Manager, Product Current

Organization Position Status
SEMAFO, Inc. President and CEO Current
Pebercan Inc. Chairman Current
Afcan Mining Corp Chairman Current
ART Advanced Research Technologies, Inc. Chairman Current
LMS Medical Systems Inc. Board of Directors Current
SEMAFO, Inc. Chairman and CEO Former
LMS Medical Systems Inc. Chairman Current
Associes Founder Former
Vasogen, Inc. Chairman Former
ART Advanced Research Technologies, Inc. Board of Directors Former
Pebercan Inc. Board of Directors Former
SEMAFO, Inc. Board of Directors Former
McGill University Masters of Business Administration from Imede, Switzerland. Former
McGill University bachelor's degree in business Former
McGill University Degree Former

George Fugelsang is the former Chief Executive Officer of Dresdner Kleinwort Benson North America, former Chairman of the Board of Dresdner Bank Mexico, S.A., former Chairman of the Board of Dresdner Bank Canada, and a member of the Board of Dresdner RCM Global Investors LLC. Prior to joining the Dresdner family, Mr. Fugelsang served as the Managing Director in Morgan Stanley s Investment Banking Division in London and spent more than twenty years at Citicorp/Citibank in various positions throughout the United States, Latin America, and Central, Southern, and Eastern Europe. Mr. Fugelsang serves as Deputy Chairman of the Board of Trustees of the Institute of International Bankers, and is a member of the Board of Trustees of Thunderbird (the American Graduate School of International Management) and the Board of Trustees of the Arthur F. Burns Fellowship. He is also a member of the Board of the German American Chamber of Commerce, Inc. and a Fellow of the Foreign Policy Association of New York. He graduated from the University of Oregon in 1962 with a dual major in Economics and Political Science. He continued his studies, pursuing a degree in foreign trade at the American Graduate School of International Management in Phoenix, Arizona, where he graduated with honors as the class valedictorian in 1963.

Organization Position Status
Energy Investors Funds Group, LLC Board of Directors Current
ART Advanced Research Technologies, Inc. Board of Directors Current
Birdsong Medical Devices Advisory Board Member Current
Dresdner Kleinwort Benson President Former
Dresdner Kleinwort Benson Chief Executive Former
Morgan Stanley Managing Director Former
Dresdner Kleinwort Wasserstein Co-Chairman Former
University of Oregon B.S. Degree In Political Science Former
American Graduate School of International Management degree in foreign trade Former

Organization Position Status
ART Advanced Research Technologies, Inc. Board of Directors Current
University of Oslo Doctorate in Neuroanatomy Former

Organization Position Status
ART Advanced Research Technologies, Inc. Board of Directors Current

Organization Position Status
ART Advanced Research Technologies, Inc. Board of Directors Current
ACE Aviation Holdings Inc. Former

Organization Position Status
ART Advanced Research Technologies, Inc. Board of Directors Current

Executive News

  • ART Advanced Research Technologies Announces Second Quarter 2009 Financial Results Conference Call

    Reuters - 8/07/09 - View Story

advertisement
ARA $20.91 +0.36 (1.75% )
Volume 511,939
Shares Outstanding 54.9M
Market Cap 1.1B
Year High 24.49
Year Low 5.29
Earnings Per Share -11.5540
P/E Ratio N/A
Dividend 3.1536
Yield 15.0818
IndustryTop Rated
advertisement